請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/102262完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 朱有田 | zh_TW |
| dc.contributor.advisor | Yu-Ten Ju | en |
| dc.contributor.author | 劉恩睿 | zh_TW |
| dc.contributor.author | En-Jui Liu | en |
| dc.date.accessioned | 2026-04-08T16:43:28Z | - |
| dc.date.available | 2026-04-09 | - |
| dc.date.copyright | 2026-04-08 | - |
| dc.date.issued | 2026 | - |
| dc.date.submitted | 2026-03-04 | - |
| dc.identifier.citation | Artigas, N., C. Ureña, E. Rodríguez-Carballo, J. L. Rosa and F. Ventura. 2014. Mitogen-activated protein kinase (MAPK)-regulated interactions between Osterix and Runx2 are critical for the transcriptional osteogenic program. Biol. Chem., 289, 27105–27117. doi.org/10.1074/jbc.M114.576793.
Amarasekara, D. S., S. Kim and J. Rho. 2021. Regulation of osteoblast differentiation by cytokine networks. Int. J. Mol. Sci, 22, 2851. doi.org/10.3390/ijms22062851. Collins, F. L., N. D. Rios-Arce, J. D. Schepper, N. Parameswaran and L. R. McCabe. 2017. The potential of probiotics as a therapy for osteoporosis. Microbiol. Spectrum, 5, 10.1128/microbiolspec.bad-0015-2016. doi.org/10.1128/microbiolspec.BAD-0015-2016. Chen, G., C. Deng and Y. P. Li. 2012. TGF-β and BMP signaling in osteoblast differentiation and bone formation. Int. J. Biol. Sci., 8, 272–288. doi.org/10.7150/ijbs.2929 Date, T., Y. Doiguchi, M. Nobuta and H. Shindo. 2004. Bone morphogenetic protein-2 induces differentiation of multipotent C3H10T1/2 cells into osteoblasts, chondrocytes, and adipocytes in vivo and in vitro. J Orthop Sci., 9, 503–508. doi.org/10.1007/s00776-004-0815-2. Derynck, R. and Y. E. Zhang. 2003. Smad-dependent and Smad-independent pathways in TGF-beta family signaling. Nature, 425, 577–584. doi.org/10.1038/nature02006. Ducy, P., R. Zhang, V. Geoffroy, A. L. Ridall, and G. Karsenty. 1997. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell, 89, 747-754. doi.org/10.1016/S0092-8674(00)80257-3. Ducy, P. and G. Karsenty. 1995. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol., 15, 1858–1869. doi.org/10.1128/MCB.15.4.1858. Gu, J. H., M. Y. Chae, J. J. Choi, T. C. Duc, C. G. Son and E. J. Lee. 2025. Deer antler velvet (Cervus elaphus sibiricus) promotes fracture healing via partial BMP2-Smad mediated osteoblast differentiation. J. Orthop. Surg. Res.;2070. doi:10.1186/s13018-024-05426-z. Hoe, H. S., D. Wessner, U. Beffert, A. G. Becker, Y. Matsuoka and G. W. Rebeck. 2005. F-spondin interaction with the apolipoprotein E receptor ApoEr2 affects processing of amyloid precursor protein. Mol. Cell. Biol., 25, 9259–9268. doi.org/10.1128/MCB.25.21.9259-9268.2005. Hauschka P. V. 1986. Osteocalcin: the vitamin K-dependent Ca2+-binding protein of bone matrix. Haemostasis, 16, 258–272. doi.org/10.1159/000215298. Izumiya, M., M. Haniu, , K. Ueda, , H. Ishida, , C. Ma, , H. Ideta, , A. Sobajima, , K. Ueshiba, , T. Uemura, , N. Saito and H. Haniu. 2021. Evaluation of MC3T3-E1 cell osteogenesis in different cell culture media. Int. J. Mol. Sci., 22, 7752. doi.org/10.3390/ijms22147752. Komori T. 2002. Runx2, a multifunctional transcription factor in skeletal development. Cell. Biochem., 87, 1–8. doi.org/10.1002/jcb.10276. Katagiri, T., A. Yamaguchi, M. Komaki, E. Abe, N. Takahashi, T. Ikeda, V. Rosen, J. M. Wozney, A. Fujisawa-Sehara and T. Suda. 1994. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. JCB., 127, 1755–1766. doi.org/10.1083/jcb.127.6.1755 Lee, K. S., H. J. Kim, Q. L. Li, X. Z. Chi, C. Ueta, T. Komori, J. M. Wozney, E. G. Kim, J. Y. Choi, H. M. Ryoo and S. C. Bae. 2000. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol. Cell. Biol, 20, 8783–8792. doi.org/10.1128/MCB.20.23.8783-8792.2000. Lu, X., Gilbert, X. He, J. Rubin and M. S. Nanes. 2006. Transcriptional regulation of the osterix (Osx, Sp7) promoter by tumor necrosis factor identifies disparate effects of mitogen-activated protein kinase and NF kappa B pathways. Biol. Chem., 281, 6297–6306. doi.org/10.1074/jbc.M507804200. Li, C. 2023. Deer antler renewal gives insights into mammalian epimorphic regeneration. Cell Regen.;12:26. doi:10.1186/s13619-023-00169-4. Liu, Q., M. Li, S. Wang, Z. Xiao, Y. Xiong and G. Wang. 2020. Recent advances of Osterix transcription factor in osteoblast differentiation and bone formation. Front. Cell Dev. Biol, 8, 601224. doi.org/10.3389/fcell.2020.601224. Nakashima, K., X. Zhou, G. Kunkel, Z. Zhang, J. M. Deng, R. R. Behringer and B. de Crombrugghe. 2002. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell, 108, 17–29. doi.org/10.1016/s0092-8674(01)00622-5. Nishio, Y., Y. Dong, M. Paris, R. J. O'Keefe, E. M. Schwarz and H. Drissi. 2006. Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene. Gene, 372, 62–70. doi.org/10.1016/j.gene.2005.12.022. Ortuño, M. J., S. Ruiz-Gaspà, E. Rodríguez-Carballo, A. R. Susperregui, R. Bartrons, J. L. Rosa, and F. Ventura. 2010. p38 regulates expression of osteoblast-specific genes by phosphorylation of osterix. Biol. Chem., 285, 31985–31994. doi.org/10.1074/jbc.M110.123612. Orimoto, A., M. Kurokawa, K. Handa, M. Ishikawa, E. Nishida, M. Aino, A. Mitani, M. Ogawa, T. Tsuji and M. Saito. 2017. F-spondin negatively regulates dental follicle differentiation through the inhibition of TGF-β activity. Arch. Oral Biol., 79, 7–13. doi.org/10.1016/j.archoralbio.2017.02.019. Palmer, G. D., M. G. Attur, Q. Yang, J. Liu, P. Moon, F. Beier and S. B. Abramson. 2014. F-spondin deficient mice have a high bone mass phenotype. PloS one, 9, e98388. doi.org/10.1371/journal.pone.0098388. Subramaniam, M., K. S. Pitel, S. G. Withers, H. Drissi and J. R. Hawse. 2016. TIEG1 enhances Osterix expression and mediates its induction by TGFβ and BMP2 in osteoblasts. Biochem. Biophys. Res. Commun., 470, 528–533. doi.org/10.1016/j.bbrc.2016.01.112. Talukdar, P. D. and U. Chatterji. 2023. Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases. Signal Transduct Target Ther., 8, 427. doi.org/10.1038/s41392-023-01651-w. Ulsamer, A., M. J. Ortuño, S. Ruiz, A. R. Susperregui, N. Osses, J. L. Rosa, and F. Ventura. 2008. BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38. Biol. Chemy., 283, 3816–3826. doi.org/10.1074/jbc.M704724200. Yao, B., C. Wang,Z. Zhou, M. Zhang, D. Zhao, X. Bai and X. Leng. 2020. Comparative transcriptome analysis of the main beam and brow tine of sika deer antler provides insights into the molecular control of rapid antler growth. Cell Mol. Biol. Lett. 25, 42. doi.org/10.1186/s11658-020-00234-9. Zhu, G., T. Zhang, M. Chen, K. Yao, X. Huang, B. Zhang, Y. Li, J. Liu, Y. Wang and Z. Zhao. 2021. Bone physiological microenvironment and healing mechanism: Basis for future bone-tissue engineering scaffolds. Bioact. Mater, 6, 4110–4140. doi.org/10.1016/j.bioactmat.2021.03.043. | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/102262 | - |
| dc.description.abstract | 鹿角是哺乳動物中唯一具有自然再生循環機制的組織,其快速生長的調控機制對骨科醫學具重要啟發。本實驗室先前在鹿茸發育的研究中,發現了胞外基質醣蛋白 F-spondin (Spon1) 的多態性;文獻亦指出 F-spondin 可能透過拮抗 BMP/SMAD 訊息傳導路徑,進而降低 RUNX2 或 Osterix (OSX) 等轉錄因子的活性,最終抑制成骨細胞(Osteoblast)的分化與成熟。然而,關於 F-spondin 是否直接影響成骨關鍵基因的轉錄活性,目前尚缺乏直接的分子證據。骨骼的形成與發育是一個精密的調控過程,其中成骨分化中期的關鍵轉錄因子 Osterix (Osx) 與晚期特異性基因 Osteocalcin (Ocn) 在成骨細胞的成熟與礦化過程中扮演決定性角色。為了深入探討成骨分化的分子調控機制,並驗證 F-spondin 的直接轉錄抑制作用,本研究旨在建立以 Osx 與 Ocn 啟動子驅動螢光素酶(Luciferase)之 MC3T3-E1 穩定細胞株模型。本研究首先從小鼠 C2C12 細胞基因組中選殖出 1.2 kb 的 Osx 啟動子與 1 kb 的 Ocn 啟動子片段,將其構築至 pGL4.18 報告載體中,分別建立 pGL4.18/osx-pro 與 pGL4.18/ocn-pro 質體。序列分析結果顯示,選殖之啟動子片段雖存在部分單核苷酸多態性(SNP),但仍保留關鍵的 RUNX2 與 OSX 轉錄因子結合位點。將建構載體轉染至 MC3T3-E1 細胞後,利用 G418 抗生素篩選出穩定表現的細胞株。試驗結果顯示,在分化培養液或 BMP-2 的誘導下,穩定細胞株中的 Osx 與 Ocn 啟動子活性均顯著上升,且 Ocn 啟動子的誘導倍數顯著高於 Osx 啟動子。此外,過量表現上游轉錄因子 RUNX2 亦能有效活化這兩個啟動子,證實此模型能忠實反映成骨訊號的轉錄調控。進一步利用此模型探討胞外基質蛋白 F-spondin 對成骨分化的影響,結果發現 F-spondin 能顯著抑制由 BMP-2 誘導的 Osx 與 Ocn 啟動子活性,證實其具備成骨負調控之能力。綜上所述,本研究成功建立了具備功能性 Osx 與 Ocn 啟動子活性檢測能力的 MC3T3-E1 穩定細胞株。此模型不僅證實了 F-spondin 的直接抑制作用,未來亦可作為研究鹿茸發育調控機制及解析相關訊息傳遞路徑(如 TGF-β 與 BMP 路徑平衡)之重要工具。 | zh_TW |
| dc.description.abstract | Deer antlers are the only mammalian tissues possessing a natural regenerative cycle, and their rapid growth regulatory mechanisms provide crucial insights for orthopedics. Previous studies in our laboratory identified polymorphisms in the extracellular matrix glycoprotein F-spondin (Spon1) during antler development. While literature suggests F-spondin may inhibit osteoblast differentiation and maturation by antagonizing the BMP/SMAD signaling pathway—thereby reducing the activity of transcription factors such as RUNX2 and Osterix (OSX)—direct molecular evidence regarding its effect on the transcriptional activity of key osteogenic genes remains lacking. Bone formation and development is a precisely regulated process, in which the mid-stage osteogenic transcription factor Osterix (Osx) and the late-stage specific gene Osteocalcin (Ocn) play decisive roles in osteoblast maturation and mineralization. To investigate the molecular regulatory mechanisms of osteogenic differentiation and verify the direct transcriptional inhibitory effect of F-spondin, this study aimed to establish MC3T3-E1 stable cell line models expressing luciferase driven by Osx and Ocn promoters. First, 1.2 kb Osx and 1 kb Ocn promoter fragments were cloned from the mouse C2C12 genome and inserted into pGL4.18 reporter vectors to construct pGL4.18/osx-pro and pGL4.18/ocn-pro plasmids, respectively. Sequence analysis revealed that although the cloned promoter fragments contained partial single nucleotide polymorphisms (SNPs), they retained critical binding sites for RUNX2 and OSX transcription factors. After transfecting these vectors into MC3T3-E1 cells, stable cell lines were selected using G418 antibiotic. The results demonstrated that Osx and Ocn promoter activities in the stable cell lines significantly increased under induction with differentiation medium or BMP-2, with the Ocn promoter showing a significantly higher fold induction than the Osx promoter. Additionally, overexpression of the upstream transcription factor RUNX2 effectively activated both promoters, confirming that this model faithfully reflects the transcriptional regulation of osteogenic signals. Furthermore, utilizing this model to explore the effect of the extracellular matrix protein F-spondin revealed that it significantly inhibited the BMP-2-induced Osx and Ocn promoter activities, demonstrating its capacity for negative regulation of osteogenesis. In conclusion, this study successfully established MC3T3-E1 stable cell lines capable of functionally monitoring Osx and Ocn promoter activities. This model not only confirms the inhibitory effect of F-spondin but also serves as a vital tool for future research on antler development mechanisms and the analysis of related signaling pathways, such as the balance between the TGF-β and BMP pathways. | en |
| dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2026-04-08T16:43:28Z No. of bitstreams: 0 | en |
| dc.description.provenance | Made available in DSpace on 2026-04-08T16:43:28Z (GMT). No. of bitstreams: 0 | en |
| dc.description.tableofcontents | 口試委員會審定書………………………………………………………………………i
誌謝………………………………………. …………………………………………….ii 中文摘要 …………………………………………………………………..…………..iii Abstract …………………………………………………………………..…………....iv 目次 …………………………………………………………………………………....vi 圖次 …………………………………………………………………………………... ix 附錄 ………………………..…………………………………………………………...x 文獻探討 ……………………………………………………………………………….1 一、 骨骼細胞的形成(骨化作用)與成骨細胞的分化機制 ……………………...1 (一) 哺乳動物骨骼的形成機制概述 ……………………………………………1 (二) 成骨細胞的分化階段 ………………………………………………………2 (三) 關鍵轉錄因子之關係 ………………………………………………………4 二、 成骨基因的表現與調控 …………………………………………………….6 (一) 調控成骨基因表現的主要訊號傳遞途徑 …………………………………6 三、 成骨基因啟動子區域的研究與功能意義 ………………………………….7 (一) 啟動子結構與功能 …………………………………………………………7 (二) Osterix啟動子或Osteocalcin啟動子對了解骨分化調控機制之重要性 ..8 (三) 螢光素酶報導基因系統於啟動子活性分析之應用 ………………………8 四、 胞外基質F-spondin對於成骨分化的調控潛力 …………………………...9 (一) F-spondin與鹿茸生長之關係 ……………………………………………...9 (二) F-spondin對於TGF-β 與 BMP 訊號路徑之調控 ……………………..10 研究目的 …………………………………………………………………………..….11 材料方法 ……………………………………………………………………………...12 一、 細胞培養 …………………………………………………………………...12 (一) 解凍活化細胞 ………………………………………………………...12 (二) 細胞繼代 ……………………………………………………………...12 (三) 冷凍保存細胞 ………………………………………………………...13 二、 Osterix 1.2kb啟動子與Osteocalcin 1 kb啟動子選殖 ………...................13 (一) 小鼠肌母細胞C2C12 genome DNA抽取 …………………………..13 (二) 聚合酶連鎖反應 ……………………………………………………..14 (三) TA-cloning …………………………………………………………….15 (四) 抽取小量質體DNA …………………………………………………..16 (五) 建立pGL4.18/osx-pro與pGL4.18/ocn-pro ……………………….....17 (六) 抽取大量質體DNA …………………………………………………..19 三、 透過特定分子訊號路徑誘導pGL4.18/osx-pro或pGL4.18/ocn-pro報告質體在成骨細胞系中啟動轉錄活性 ………………………………...………20 (一) 短暫轉染 (Transient transfection) …………………………………..20 (二) BMP-2 treating ……………………...……………………………….21 (三) 雙螢光素酶系統 …………………………………………………....21 四、 Alizarin Red S Staining 茜素红染色檢測成骨細胞鈣沉積 ……………...22 五、 Alkaline phosphatase Staining鹼性磷酸酶染色檢測細胞分化訊號…........22 六、 建立MC3T3-E1/osx-pro與MC3T3-E1/ocn-pro穩定表現細胞株 ...…....23 七、 統計方法 ……………………………………………...…………………... 23 結果 …………………………………………………………………………………...24 一、 建構Osterix啟動子驅動螢光素酶的表現載體 ………………...........…..24 二、 建構Osteocalcin啟動子驅動螢光素酶的表現載體 ……………………..24 三、 啟動子序列中的轉錄因子結合位點 ……………………………………...24 四、 MC3T3-E1的分化與鈣化檢測 ……………………………………………25 五、 外源性表現啟動子分化誘導 ……………………………………………...25 六、 外源性表現啟動子BMP-2處理 ………………………………………….26 七、 建立穩定表現啟動子表現載體的MC3T3-E1細胞株 ………..……….…26 八、 Runx2對成骨特異性基因啟動子活性之影響 ………………...………….26 九、 F-spondin與Reelin對成骨特異性基因啟動子活性之影響 ……………..27 討論 ………………………………………………………………………...................28 一、 啟動子序列分析與轉錄因子結合位點的生物意義 ……………………...28 二、 Ocn與Osx啟動子對誘導訊號的差異反應機制 ……………...…………28 三、 建立穩定細胞株在成骨分化研究中的必要性 ……………………….......29 四、 Runx2對成骨基因的劑量依賴性調控 ……………………………………29 五、 模型檢測成骨調控因子之應用—以F-spondin為例 …………………….30 結論 …………………………………………………………………………………...31 參考文獻 …………………………………………………………...............................32 | - |
| dc.language.iso | zh_TW | - |
| dc.subject | 成骨分化 | - |
| dc.subject | Osterix | - |
| dc.subject | Osteocalcin | - |
| dc.subject | 啟動子 | - |
| dc.subject | F-spondin | - |
| dc.subject | Osteogenic differentiation | - |
| dc.subject | Osterix | - |
| dc.subject | Osteocalcin | - |
| dc.subject | Promoter | - |
| dc.subject | F-spondin | - |
| dc.title | 建立成骨分化細胞株中成骨特異性基因Osterix與Osteocalcin啟動子活性之檢測模型 | zh_TW |
| dc.title | Development of the cell-based model for monitoring promoter activities of osteoblast-specific genes Osterix and Osteocalcin | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 114-2 | - |
| dc.description.degree | 碩士 | - |
| dc.contributor.oralexamcommittee | 王詩凱;楊瀅臻;黃瀞瑩 | zh_TW |
| dc.contributor.oralexamcommittee | Shih-Kai Wang;Ying-Chen Yang;Ching-Ying Huang | en |
| dc.subject.keyword | 成骨分化,OsterixOsteocalcin啟動子F-spondin | zh_TW |
| dc.subject.keyword | Osteogenic differentiation,OsterixOsteocalcinPromoterF-spondin | en |
| dc.relation.page | 60 | - |
| dc.identifier.doi | 10.6342/NTU202600813 | - |
| dc.rights.note | 同意授權(限校園內公開) | - |
| dc.date.accepted | 2026-03-04 | - |
| dc.contributor.author-college | 生物資源暨農學院 | - |
| dc.contributor.author-dept | 動物科學技術學系 | - |
| dc.date.embargo-lift | 2031-01-30 | - |
| 顯示於系所單位: | 動物科學技術學系 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-114-2.pdf 未授權公開取用 | 6.49 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
